Search Results - "Conrad, David M"

Refine Results
  1. 1

    Bovine lactoferricin selectively induces apoptosis in human leukemia and carcinoma cell lines by Mader, Jamie S, Salsman, Jayme, Conrad, David M, Hoskin, David W

    Published in Molecular cancer therapeutics (01-04-2005)
    “…Bovine lactoferricin (LfcinB) is a cationic, amphipathic peptide that is cytotoxic for human and rodent cancer cells. However, the mechanism by which LfcinB…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Bone marrow necrosis and hyperinflammation after treatment with inotuzumab ozogamicin for B-cell acute lymphoblastic leukaemia by Marcoux, Curtis, Thakkar, Pinkesh, Conrad, David M, Shawwa, Allam A, Chen, Luke Y C

    Published in The Lancet (British edition) (28-09-2024)
    “…Laboratory investigations showed a white blood cell count of 2·37 × 109 per L (typical range 4·5–11·0), haemoglobin concentration was 93 g/L (typical range…”
    Get full text
    Journal Article
  4. 4

    Rapid optimized flow cytometric crossmatch (FCXM) assays: The Halifax and Halifaster protocols by Liwski, Robert S., Greenshields, Anna L., Conrad, David M., Murphey, Cathi, Bray, Robert A., Neumann, Jorge, Gebel, Howard M.

    Published in Human immunology (01-01-2018)
    “…The flow cytometric crossmatch (FCXM) assay, which detects the presence of donor specific HLA antibodies in patient sera, is a cornerstone of HLA compatibility…”
    Get full text
    Journal Article
  5. 5

    Process mining is an underutilized clinical research tool in transfusion medicine by Quinn, Jason G., Conrad, David M., Cheng, Calvino K.

    Published in Transfusion (Philadelphia, Pa.) (01-03-2017)
    “…BACKGROUND To understand inventory performance, transfusion services commonly use key performance indicators (KPIs) as summary descriptors of inventory…”
    Get full text
    Journal Article
  6. 6

    A re-examination of the role of the acute phase protein response in innate cancer defence by Conrad, David M, Hoskin, David W, Liwski, Robert, Naugler, Christopher

    Published in Medical hypotheses (01-08-2016)
    “…Abstract Anti-cancer host defense mechanisms are traditionally considered to consist of tumor suppressor genes and immune surveillance by cells of the innate…”
    Get full text
    Journal Article
  7. 7

    Inhibition of T cell and natural killer cell function by adenosine and its contribution to immune evasion by tumor cells (Review) by HOSKIN, David W, MADER, Jamie S, FURLONG, Suzanne J, CONRAD, David M, BLAY, Jonathan

    Published in International journal of oncology (01-03-2008)
    “…The resistance of many human cancers to immune-based therapies, including adoptive immunotherapy and the administration of therapeutic cancer vaccines, has…”
    Get full text
    Journal Article
  8. 8

    The Acute Phase Protein Hepcidin Is Cytotoxic to Human and Mouse Myeloma Cells by Conrad, David M, Hilchie, Ashley L, McMillan, Katelyn A M, Liwski, Robert S, Hoskin, David W, Power Coombs, Melanie R

    Published in Anticancer research (01-02-2021)
    “…Hepcidin is a cationic acute phase reactant synthesized by the liver. It has bactericidal properties and is a major regulator of iron homeostasis. Cationic…”
    Get full text
    Journal Article
  9. 9

    Adenosine Acts through A2 Receptors to Inhibit IL-2-Induced Tyrosine Phosphorylation of STAT5 in T Lymphocytes: Role of Cyclic Adenosine 3',5'-Monophosphate and Phosphatases by Zhang, Hong, Conrad, David M, Butler, Jared J, Zhao, Chuanli, Blay, Jonathan, Hoskin, David W

    Published in The Journal of immunology (1950) (15-07-2004)
    “…Adenosine is a purine nucleoside with immunosuppressive activity that acts through cell surface receptors (A(1), A(2a), A(2b), A(3)) on responsive cells such…”
    Get full text
    Journal Article
  10. 10

    Pleurocidin-family cationic antimicrobial peptides mediate lysis of multiple myeloma cells and impair the growth of multiple myeloma xenografts by Hilchie, Ashley L., Conrad, David M., Power Coombs, Melanie R., Zemlak, Tyler, Doucette, Carolyn D., Liwski, Robert S., Hoskin, David W.

    Published in Leukemia & lymphoma (01-10-2013)
    “…Abstract Multiple myeloma is a common hematological malignancy that urgently requires new approaches to treatment, since the disease is not curable using…”
    Get full text
    Journal Article
  11. 11

    Apoptosis induced by protein phosphatase 2A (PP2A) inhibition in T leukemia cells is negatively regulated by PP2A-associated p38 mitogen-activated protein kinase by Boudreau, Robert T.M., Conrad, David M., Hoskin, David W.

    Published in Cellular signalling (2007)
    “…Serine/threonine phosphatase regulation of phosphorylation-mediated intracellular signaling controls a number of important processes in mammalian cells. In…”
    Get full text
    Journal Article
  12. 12

    The hardscrabble hypothesis: A reduction in chronic tissue damage has increased the incidence of autoimmune disease by Naugler, Christopher, Conrad, David M

    Published in Medical hypotheses (01-02-2010)
    “…Summary The adaptive immune system, fine tuned through millions of years of vertebrate evolution, discriminates self from foreign antigens through the deletion…”
    Get full text
    Journal Article
  13. 13

    Extensive Neurocristic Hamartoma With Bone Marrow Involvement by CONRAD, David M, CHAPLIN, Anna, WALSH, Noreen M, PASTERNAK, Sylvia

    Published in The American journal of dermatopathology (01-07-2010)
    “…Cutaneous neurocristic hamartoma (NCH) is a rare, pigmented lesion consisting of cells that aberrantly develop from the neurocrest. In addition to a dermal…”
    Get full text
    Journal Article
  14. 14

    Curcumin blocks interleukin (IL)-2 signaling in T-lymphocytes by inhibiting IL-2 synthesis, CD25 expression, and IL-2 receptor signaling by Forward, Nicholas A., Conrad, David M., Power Coombs, Melanie R., Doucette, Carolyn D., Furlong, Suzanne J., Lin, Tong-Jun, Hoskin, David W.

    “…► Curcumin inhibits CD4+ T-lymphocyte proliferation. ► Curcumin inhibits interleukin-2 (IL-2) synthesis and CD25 expression by CD4+ T-lymphocytes. ► Curcumin…”
    Get full text
    Journal Article
  15. 15

    Mixed phenotype acute leukemia, B/myeloid, NOS with near-tetraploidy: a case report by Nix, Kimberley M, Harrison, Karen J, Shivakumar, Sudeep P, Shawwa, Allam A, Conrad, David M

    “…Acute leukemia in adults is usually associated with a myeloid phenotype, and less commonly presents as an acute lymphocytic leukemia. Rarely, the leukemic…”
    Get full text
    Journal Article
  16. 16

    Primary Cutaneous PEComa by CHAPLIN, Anna, CONRAD, David M, TATLIDIL, Cuneyt, JOLLIMORE, Jason, WALSH, Noreen, COVERT, Alan, PASTERNAK, Sylvia

    Published in The American journal of dermatopathology (01-05-2010)
    “…A 48-year-old woman attended a physician because of a solitary cutaneous nodule on the left lower leg. Microscopic examination of the excisional specimen…”
    Get full text
    Journal Article
  17. 17

    The Ca2+ channel blocker flunarizine induces caspase-10-dependent apoptosis in Jurkat T-leukemia cells by Conrad, David M., Furlong, Suzanne J., Doucette, Carolyn D., West, Kenneth A., Hoskin, David W.

    Published in Apoptosis (London) (01-05-2010)
    “…Flunarizine is a Ca 2+ channel blocker that can be either cytoprotective or cytotoxic, depending on the cell type that is being examined. We show here that…”
    Get full text
    Journal Article
  18. 18

    The Ca(2+) channel blocker flunarizine induces caspase-10-dependent apoptosis in Jurkat T-leukemia cells by Conrad, David M, Furlong, Suzanne J, Doucette, Carolyn D, West, Kenneth A, Hoskin, David W

    Published in Apoptosis (London) (01-05-2010)
    “…Flunarizine is a Ca(2+) channel blocker that can be either cytoprotective or cytotoxic, depending on the cell type that is being examined. We show here that…”
    Get full text
    Journal Article
  19. 19

    Role of mitogen-activated protein kinases in Thy-1-induced T-lymphocyte activation by Conrad, David M., Furlong, Suzanne J., Doucette, Carolyn D., Boudreau, Robert T.M., Hoskin, David W.

    Published in Cellular signalling (01-08-2009)
    “…Thy-1 (CD90) crosslinking by monoclonal antibodies (mAb) in the context of costimulation causes the activation of mouse T-lymphocytes; however, the associated…”
    Get full text
    Journal Article
  20. 20

    Induction of CD4 CD25 Foxp3 regulatory T cells by Thy-1 stimulation of CD4 T cells by Conrad, David M, Coombs, Melanie R Power, Furlong, Suzanne J, Forward, Nicholas A, Hoskin, David W

    Published in Immunology and cell biology (01-02-2012)
    “…Thy‐1 (CD90) on mouse T cells has been reported to have both T‐cell activating and regulatory roles. In this study, we show that monoclonal antibody…”
    Get full text
    Journal Article